PHC Holdings

Basic Information

Stock Code
6523
Industry
Electric Machinery
Category Detail
Commercial & Industrial Machinery
Prefecture
Tokyo
Establishment Year
August 2013
Listing Year
October 2021
Official Website
https://www.phchd.com/jp
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
CVS Bay Area, Nippon Fine Chemical, Terumo, Technomedica, Rion, Nihon Kohden, Fukuda Denshi, Yagami, Japan M.D.M., Nakanishi, Olympus, Cyberdyne, Nac

Overview

PHC Holdings is a global healthcare company established in 2013, a domestic leader with strengths in medical devices, healthcare IT, and life sciences businesses.

Current Situation

PHC Holdings recorded consolidated sales of approximately 356.4 billion yen and operating profit of 20 billion yen in the fiscal year ended March 2023, but posted a net loss of about 3 billion yen due to the burden of goodwill amortization. In its core medical devices segment, it holds the top domestic market share in blood glucose monitoring systems and ultra-low temperature freezers, establishing a global niche leadership position. In recent years, it has actively expanded through acquisitions such as Thermo Fisher Scientific's pathology business and Fujifilm's electronic medical records business. Demand for ultra-low temperature freezers surged during the COVID-19 pandemic, keeping manufacturing sites at full capacity. While reducing substantial acquisition-related debt remains a financial challenge, growth is expected through technological innovation and overseas expansion. Under its medium-term management plan 'Value Creation Plan,' it emphasizes revenue improvement and healthcare IT enhancement through fiscal 2024. As a company listed on the Tokyo Stock Exchange Prime Market, it aims to maintain competitiveness in the healthcare sector and achieve sustainable growth.

Trivia

Interesting Facts

  • PHC boasts world No. 2 and domestic No. 1 share in ultra-low temperature freezers
  • Medical device manufacturer originating from Panasonic Healthcare's history
  • Contributed to society by providing essential equipment for COVID-19 vaccine storage
  • Inherits lineage of company involved in proprietary VX video format development
  • Major shareholders include prominent funds like Kohlberg Kravis Roberts (KKR)
  • Key player in Japan's pathology diagnostic equipment market following Thermo Fisher Scientific
  • Japan's only company providing WADA-certified doping tests
  • Actively pursues numerous acquisitions to diversify and grow business
  • Head store in Toon City, Ehime Prefecture, is historic base of former Panasonic Healthcare
  • Actively expanding into electronic medical records field to grow medical IT market
  • Rare domestic medical device company also manufacturing medical reagents and testing drugs
  • Expands clinical testing and health check support through numerous subsidiaries
  • Approximately 9,400 employees, large-scale for a medical device manufacturer
  • New head office located in Dai-ichi Life Hibiya First Building, Chiyoda-ku, Tokyo
  • Company name PHC derives from Precision Healthcare Corporation

Hidden Connections

  • Inherits technology and management resources nurtured as former Panasonic subsidiary, maintaining relationship even after independence
  • Supported by multiple major funds including KKR as shareholders
  • Acquired pathology business from Thermo Fisher Scientific to become a global key player
  • Strategic relationship through acquisition of Fujifilm's electronic medical records business to strengthen medical IT field
  • Japan's only company providing WADA-certified testing through subsidiaries
  • Ultra-low temperature freezer manufacturing base located at factory inherited from Sanyo Electric's commercial refrigerator division
  • Listed on TSE in 2021 as exit strategy for healthcare-focused funds
  • Diabetes-related products feature market-standard technology and collaborate with multiple related companies domestically and internationally

Future Outlook

Growth Drivers

  • Increased demand for medical devices due to global aging
  • Ongoing demand for ultra-low temperature freezers expanded by COVID-19
  • Advancement of IT adoption in medical IT and electronic medical records field
  • Increased equipment investment in life sciences research field
  • Expansion and diversification of clinical testing outsourcing business
  • Strengthening of sales networks in overseas markets
  • Improved competitiveness through new product development
  • Business diversification and synergy creation through acquisitions
  • Development of sustainability-compliant products and services
  • Advancement of digitalization and data analysis technologies
  • New market entry through strengthened partnerships
  • Growing demand for health management and preventive medicine solutions

Strategic Goals

  • Establish top-class global presence in medical device market
  • Improve sustainable product ratio to over 70%
  • Achieve sales exceeding 500 billion yen
  • Product diversification in medical IT and life sciences fields
  • Innovative technology creation through increased R&D investment
  • Expansion in digital health domain
  • Achieve global environmental load reduction and decarbonization goals
  • Promote diversity and inclusion and strengthen talent development
  • Build strong partnerships with medical institutions
  • Strengthen sustainable contributions to local communities

Business Segments

Medical Device Manufacturing and Sales

Overview
Develops, manufactures, sells, and provides services for a wide range of medical devices.
Competitiveness
Maintains high technological capabilities and brand recognition both domestically and internationally.
Customers
  • Hospitals
  • Clinics
  • Medical Device Dealers
  • Pharmaceutical Companies
  • Testing Institutions
Products
  • Blood Glucose Monitoring Systems
  • Ultra-Low Temperature Freezers
  • Clinical Testing Equipment
  • Pathology Diagnostic Equipment

Medical IT Solutions

Overview
IT systems that support efficiency and quality improvement in medical settings.
Competitiveness
One-stop solutions integrated with medical devices.
Customers
  • Medical Institutions
  • Pharmacies
  • Health Check Centers
  • Pharmaceutical Companies
Products
  • Electronic Medical Records
  • Electronic Medication History Systems
  • Health Management Software
  • Clinical Testing Services

Life Science Equipment Business

Overview
Demonstrates expertise in developing and selling equipment for cutting-edge research.
Competitiveness
Differentiation through high value-added products.
Customers
  • Biotechnology Companies
  • Research Institutions
  • Clinical Research Institutions
  • Pharmaceutical Companies
Products
  • Ultra-Low Temperature Storage Equipment
  • Culture Equipment
  • Laboratory Environment Equipment
  • Automated Tablet Packaging Machines for Pharmacies

Clinical Testing Outsourcing Services

Overview
Expands clinical testing business centered on pharmaceutical development support.
Competitiveness
Certified testing system by the World Anti-Doping Agency.
Customers
  • Pharmaceutical Companies
  • Medical Institutions
  • CRO
  • Health Check Services
Products
  • Clinical Trial Outsourcing
  • Testing Services
  • Clinical Trial Support

Health Check and Preventive Medicine Support Business

Overview
Provides equipment and support services for health checks.
Competitiveness
One-stop provision with strength in preventive medicine.
Customers
  • Health Check Centers
  • Health Insurance Associations
  • Corporate Health Management Departments
Products
  • Health Check Equipment
  • Preventive Medicine Solutions

Electronic Medical Records and Medical IT Services

Overview
Provides IT solutions for medical institutions.
Competitiveness
Stable operations and extensive track record.
Customers
  • Clinics
  • Hospitals
  • Insurance Pharmacies
Products
  • Electronic Medical Records
  • Medical Affairs Computers
  • Electronic Medication History Systems

Medical Consumables and Peripheral Equipment

Overview
Peripheral equipment supporting efficiency in medical settings.
Competitiveness
Total services integrated with medical devices.
Customers
  • Medical Institutions
  • Pharmacies
Products
  • Syringes
  • Automated Tablet Packaging Machines
  • Pharmacy Meal Delivery Carts

Regenerative Medicine Related Equipment

Overview
Advanced research equipment supporting the development of regenerative medicine.
Competitiveness
Differentiation through specialized technology and quality control systems.
Customers
  • Regenerative Medicine Companies
  • Research Institutions
Products
  • Regenerative Medicine Culture Equipment
  • Cell Storage Equipment

Overseas Sales and Service Business

Overview
Sales and after-sales services specialized for overseas markets.
Competitiveness
Global sales network.
Customers
  • Overseas Medical Institutions
  • Medical Distributors
Products
  • Medical Devices
  • Maintenance Services

Medical Environment Equipment

Overview
Provides environmental maintenance equipment for medical and research facilities.
Competitiveness
Proven track record in high reliability and safety.
Customers
  • Hospitals
  • Testing Labs
Products
  • Dry Heat Equipment
  • Dryers

Medical Imaging and Diagnostic Equipment

Overview
Provides medical equipment supporting advanced diagnostic technologies.
Competitiveness
Technology enhancement through acquisitions.
Customers
  • Medical Institutions
Products
  • Pathology Diagnostic Equipment
  • Ultrasound Diagnostic Equipment

Life Science Research Equipment

Overview
Range of equipment supporting cutting-edge bio research.
Competitiveness
Diverse product lineup.
Customers
  • Pharmaceutical Companies
  • Research Institutions
Products
  • Culture Equipment
  • Cell Storage Equipment
  • Research Consumables

Competitive Advantage

Strengths

  • Domestic top market share in ultra-low temperature freezers
  • High technological capabilities in diabetes management devices
  • Business diversification through extensive acquisition experience
  • Global sales and service network
  • Development capabilities in medical IT products across multiple fields
  • Strong capital base from stable major shareholders
  • Advanced clinical testing and pathology diagnostic technologies
  • Proven track record in medical devices with long history
  • High specialization focused on medical field
  • Strong domestic and international partnerships
  • High brand recognition and reliability
  • Regulatory compliance capabilities domestically and internationally
  • Established diverse sales channels
  • Active investment in technological innovation
  • Extensive product lineup

Competitive Advantages

  • World No. 2 ultra-low temperature freezer share following Thermo Fisher
  • Manufacturing capacity that captured vaccine storage demand during COVID-19
  • Deployment of industry-standard products in diabetes sensor field
  • One-stop solutions through integration of diverse medical IT systems
  • Expansion into bio and life sciences through numerous acquisitions
  • Market trust from listing on Tokyo Stock Exchange Prime Market
  • Provision of testing services certified by World Anti-Doping Agency
  • Ownership of largest-scale domestic manufacturing and development bases
  • Strong capital backing from KKR, Mitsui & Co., and others
  • Rich medical device brands and long-term market track record
  • Competitiveness through advanced technology and broad product lineup
  • Ongoing reinforcement of medical IT products like electronic medical records
  • Compliance with international standards and quality assurance systems
  • High R&D capabilities and product reliability
  • Broad customer base and sales network

Threats

  • Financial strain risk from substantial goodwill
  • Burden of responding to frequent changes in medical device regulations
  • Intense price competition and market contraction domestically and internationally
  • Market share erosion by new entrants and major competitors
  • Risk of global supply chain disruptions
  • Potential demand decline post-COVID-19
  • Risk of failing to keep pace with technological innovation speed
  • Earnings impact from exchange rate fluctuations
  • Equipment investment restraint due to uncertain economic conditions
  • Increased business operation costs from strengthened regulations
  • Patent disputes and intellectual property risks
  • Intensified competition for talent acquisition

Innovations

2023: Acquisition of Fujifilm's Electronic Medical Records Business

Overview
Acquired the electronic medical records business for approximately 10 billion yen to strengthen medical IT.
Impact
Significantly improved market competitiveness in medical IT field.

2021: Listing on Tokyo Stock Exchange Prime Market

Overview
Transitioned to Prime Market after listing on Market First Section to enhance corporate value.
Impact
Improved fundraising capabilities and market trust.

2020: Ultra-Low Temperature Freezer Production Expansion for COVID-19 Response

Overview
Expanded to 2-3 shift system in response to increased vaccine storage demand.
Impact
Significant sales increase in short term, strengthening industry position.

2020: Acquisition of AmeriPharma Shares to Strengthen Medical Services

Overview
Acquired 50.9% stake to make it a consolidated subsidiary for advanced data analysis system development.
Impact
Successfully advanced healthcare services business.

2020: Strategic Business Alliance with Senseonics

Overview
Concluded global exclusive distribution agreement to expand product lineup.
Impact
Expanded market share and promoted technological innovation.

2023: Full Subsidiary of SciMed (Asia)

Overview
Additional share acquisition to strengthen life sciences business base in Asia market.
Impact
Expanded regional business and increased sales.

2023: Establishment of Mediford Co., Ltd. and Business Integration

Overview
Inherited clinical trial business to strengthen clinical testing service system.
Impact
Contributed to service efficiency and quality improvement.

2021: Formulation of Medium-Term Management Plan 'Value Creation Plan'

Overview
Formulated revenue structure reform and growth strategy for fiscal 2021-2024.
Impact
Strengthened business foundation and established revenue growth trend.

2022: Head Office Relocation to Dai-ichi Life Hibiya First

Overview
Relocated head office to improve operational efficiency and refresh brand image.
Impact
Improved internal communication and operational efficiency.

2023: Goodwill Impairment Response for Pathology Business

Overview
Recorded impairment on goodwill from Thermo Fisher pathology business acquisition to normalize finances.
Impact
Management decision leading to improved financial soundness.

Sustainability

  • Reduced environmental impact through improved energy efficiency of ultra-low temperature freezers
  • Health promotion activities through collaboration with local communities
  • Organizational revitalization through promotion of diversity and inclusion
  • Strengthened corporate governance and improved transparency
  • Management of environmental and social risks in supply chain